Founded in 1999, ChrysCapital is India's largest and most established private equity firm, using deep domain expertise to make growth and control investments across financial services, healthcare, consumer, manufacturing, and enterprise technology sectors.
They made 1 investments in the last 12 months. Average disclosed round size is $140.8M (across 16 rounds with reported amounts).
Portfolio
15
Fund Size
$2.2B
Top Stage
Unknown
Last 12 Mo
1
Team
Sanjay Kukreja
Managing Partner
Kshitij Sheth
Managing Director
Raghav Ramdev
Managing Director
Saurabh Chatterjee
Managing Director
Ashley Menezes
Senior Partner
Christian Schlumberger
Director
Abhishek Gupta
Senior Vice President
Arpit Vinayak
Senior Vice President
Aditi Jain
Investment Professional
Chaitanya Agnihotri
Private Equity
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 MoEngage | Series F | $180M | Dec 2025 |
 GeBBS Healthcare Solutions | Unknown | $85M | Jan 2024 |
 Lenskart | Unknown | $100M | Jun 2023 |
| LLENSKART SOLUTIONS PRIVATE LIMITED | Unknown | $600M | Jan 2023 |
 HealthKart | Series H | $135M | Jan 2022 |
 WOW Skin Science | Unknown | $48.0M | Jan 2022 |
 Dream Sports | Growth | — | Mar 2021 |
| DDreamX | Unknown | $400M | Jan 2021 |
| Dream Sports | Growth | $225M | Sep 2020 |
| DDreamX | Series D | $225M | Jan 2020 |
 Awfis | Series D | $30M | Aug 2019 |
| DDreamX | Unknown | $60M | Jan 2019 |
 Acko | Series A | $12M | May 2018 |
| CCuratio Healthcare | Unknown | $20M | — |
 The Sleep Company | Series D | — | — |
 Infogain | Unknown | $63M | — |
 Ipca Laboratories | Unknown | $20M | — |
| AAU Financiers | Unknown | $50M | — |
Top Co-Investors
Last updated: 9 September 2026